查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1320243

慢病毒載體 CDMO（合同製造組織）市場：按成分,按疾病適應症,按最終用戶,按國家,按地區 - 行業分析,市場規模,市場份額,預測 2023-2030 年

Lentiviral Vector Contract Development & Manufacturing Organizations Market with COVID-19 Impact Analysis, By Component, Disease Indication, End User, Country, & Region-Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 359 Pages | 商品交期: 2-3個工作天內

價格

報告要點

慢病毒載體 CDMO（合同研究和製造組織）市場規模將於 2022 年達到 1.522 億美元，2023 年至 2030 年復合年增長率為 6.2%

慢病毒載體 CDMO 市場 - 市場動態：

對細胞和基因治療的日益關注預計將推動對慢病毒載體 CDMO 的需求

許多遺傳性和獲得性疾病，包括癌症,罕見的遺傳異常和自身免疫性疾病，都顯示出基因和細胞療法治療的巨大潛力。 隨著更多潛在治療靶點的發現和驗證，對慢病毒載體（將治療基因傳遞到靶細胞的重要資源）的需求預計將會增長。 離體基因編輯和修飾細胞療法只是利用慢病毒載體的適應性和多功能性的治療應用的幾個例子。 新療法和個性化醫療策略的研究增加了對使用慢病毒載體的 CDMO 的需求。

此外，基因和細胞療法的開發得到了歐洲藥品管理局 (EMA) 和美國食品和藥物管理局 (FDA) 等監管機構的支持。 為支持此類新藥的研究和營銷而提供的加快監管流程和其他激勵措施增加了對可靠的慢病毒載體製造合作夥伴的需求。

慢病毒載體 CDMO 市場 - 主要見解：

  • 由於對製造業的日益關注，慢病毒載體 CDMO 行業預計將以顯著的速度增長。
  • 按照疾病適應症，預計癌症細分市場將在 2022 年佔據最大的市場份額。
  • 從最終用戶來看，預計到 2030 年，製藥和生物技術領域將佔據較大的市場份額。
  • 從組成部分來看，慢病毒啟動子部分將在 2022 年佔據主導地位。
  • 按地區劃分，北美將在 2022 年銷量領先。

慢病毒載體 CDMO 市場 - 細分分析：

全球慢病毒載體 CDMO 市場根據成分,疾病適應症,最終用戶和地區進行細分。

慢病毒啟動子,慢病毒融合標籤,慢病毒包裝系統等。 慢病毒啟動子部分主導市場。 醫療領域對慢病毒合同開發的需求不斷增加，正在促進市場發展。

市場按疾病適應症分為五類：癌症,遺傳性疾病,傳染病,動物疾病和其他。 癌症領域佔據市場主導地位。 癌症和其他疾病患病率的增加預計將推動市場增長。

市場按最終用戶分為三個部分：製藥和生物技術,學術研究和其他。 製藥和生物技術領域主導著市場。 製藥行業對醫療開發的需求不斷增長，推動了該領域的增長。

慢病毒載體 CDMO 市場 - 地理洞察：

從地理上看，該市場遍布北美,拉丁美洲,歐洲,亞太地區,中東和非洲地區。 這些地區根據引入業務的國家進一步劃分。

慢病毒載體 CDMO 市場 - 競爭格局：

慢病毒載體CDMO市場受到醫療領域快速發展和製藥領域需求不斷增加的影響。 新產品發布,研發支出,分銷網絡開發以及併購是企業鞏固市場份額和增加市場份額的關鍵技術和戰略。 以下是一些最新進展。

最近活動

2021年，牛津生物醫學公司與勃林格殷格翰簽署了一項新的為期三年的開發和供應協議，用於生產和供應病毒載體。

內容

第一章慢病毒載體 CDMO 市場概述

  • 調查範圍

第 2 章執行摘要

  • 市場細分
  • 競爭考慮因素

第三章慢病毒載體CDMO市場主要趨勢

  • 慢病毒載體 CDMO 市場驅動因素
  • 慢病毒載體CDMO市場製約因素
  • 慢病毒載體CDMO市場機會
  • 慢病毒載體CDMO市場未來趨勢

第 4 章慢病毒載體 CDMO 行業調查

  • PEST分析
  • 波特五力分析
  • 增長前景圖
  • 監管框架分析

第五章慢病毒載體 CDMO 市場：COVID-19 的影響分析

  • 新冠肺炎 (COVID-19) 疫情之前的影響分析
  • 新冠肺炎 (COVID-19) 疫情後的影響分析

第六章慢病毒載體 CDMO 市場格局

  • 2022 年慢病毒載體 CDMO 市場份額分析
  • 主要製造商的詳細數據
    • 已成立公司分析
    • 初創企業分析

第 7 章。慢病毒載體 CDMO 市場 - 按組成部分

  • 概述
    • 按組成部分分析細分市場份額
    • 慢病毒啟動子
    • 慢病毒融合標籤
    • 慢病毒包裝系統
    • 其他

第 8 章慢病毒載體 CDMO 市場 - 按疾病適應症

  • 概述
    • 按疾病適應症劃分的細分市場份額分析
    • 癌症
    • 遺傳病
    • 感染
    • 動物疾病
    • 其他

第 9 章。慢病毒載體 CDMO 市場 - 按最終用戶

  • 概述
    • 最終用戶的細分市場份額分析
    • 製藥/生物技術
    • 學術研究
    • 其他

第 10 章慢病毒載體 CDMO 市場 - 按地區

  • 簡介
  • 北美
    • 概述
    • 主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 主要製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第 11 章主要供應商分析 - 慢病毒載體 CDMO 行業

  • 競賽儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Oxford Biomedica
    • Charles River Laboratories International, Inc.
    • Creative Biogene
    • GenScript ProBio
    • Merck KGaA
    • Catalent Inc.
    • Ask Bio
    • Lonza
    • Curia Global, Inc.
    • Wuxi Advanced Therapies
    • SIRION Biotech GmbH
    • VGXI, Inc.
    • Yposkesi
    • Oxford Genetics Ltd.

第12章 分析師的全面展望

Product Code: ANV1554

REPORT HIGHLIGHT

Lentiviral Vector Contract Development and Manufacturing Organizations Market size was valued at USD 152.2 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Contract Development and Manufacturing Organizations (CDMOs) are specialized in lentiviral vector production. These organizations offer services for the development, manufacturing, and production of lentiviral vectors for gene therapy, cell therapy, and other Disease Indications.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Market Dynamics:

Growing emphasis on cell and gene therapies is expected to propel the Lentiviral Vector Contract Development and Manufacturing Organizations demand.

Numerous hereditary and acquired diseases, such as cancer, rare genetic abnormalities, and autoimmune diseases, have showed great promise in the treatment with gene and cell treatments. The need for lentiviral vectors, which are essential resources for delivering therapeutic genes to target cells, is anticipated to rise as more possible therapeutic targets are discovered and verified. Ex vivo gene editing and modified cell treatments are just a couple of the therapeutic uses for lentiviral vectors' adaptability and versatility. The investigation of novel therapeutic modalities and individualized medical strategies has increased demand for CDMOs using lentiviral vectors.

Further, the development of gene and cell therapies has received support from regulatory organizations like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The need for trustworthy lentiviral vector manufacturing partners has increased because of the quicker regulatory procedures and other incentives they have offered to support the research and marketing of these novel medicines.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Lentiviral Vector Contract Development and Manufacturing Organizations market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2023-2030)
  • The Lentiviral Vector Contract Development and Manufacturing Organizations industry is projected to grow at a significant rate due to the growing focus on manufacturing industries.
  • Based on Disease Indication, cancer segment was predicted to show maximum market share in the year 2022.
  • Based on End User, pharmaceutical & biotech segment is expected to hold significant market share by 2030.
  • Based on Component segmentation, lentiviral promoter segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Segmentation Analysis:

The Global Lentiviral Vector Contract Development and Manufacturing Organizations Market is segmented on the basis of Component, Disease Indication, End User, and Region.

The market is divided into four categories based on Component: lentiviral promoter, lentiviral fusion tags, lentivirus packaging systems and others. The lentiviral promoter segment dominates the market. Increasing demand from medical sector for lentiviral contract developments is contributing to market growth.

The market is divided into five categories based on Disease Indication: cancer, genetic disorders, infectious diseases, veterinary disease, and others. The cancer segment dominates the market. Increasing prevalence of cancer and its other disease forms is expected to boost the market growth.

The market is divided into three categories based on End User: pharmaceutical & biotech, academic research, and others. The pharmaceutical & biotech segment dominates the market. The rising demand from medical development in pharma sector is increasing the segment growth.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Competitive Landscape:

Owing to the fast development in medical, and rising demand from pharmaceutical sector, which influence the lentiviral vector contract development and manufacturing organizations market. Several companies promote their products, including corporate websites, and Disease Indications, are used by businesses to sell their solutions & Disease Indications. Composite manufacturers compete on various factors, such as composite pricing, performance, composite creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In 2021, Oxford Biomedica signed a new three-year development and supply agreement with Boehringer Ingelheim to manufacture and supply viral vectors.

Key features of the study:

  • This proposed research study on Lentiviral Vector Contract Development and Manufacturing Organizations market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Lentiviral Vector Contract Development and Manufacturing Organizations market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Lentiviral Vector Contract Development and Manufacturing Organizations market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Lentiviral Vector Contract Development and Manufacturing Organizations market
  • Impact of COVID-19 on Lentiviral Vector Contract Development and Manufacturing Organizations market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Lentiviral Vector Contract Development and Manufacturing Organizations market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Lentiviral Vector Contract Development and Manufacturing Organizations market, we have also included competitive landscape and key innovator analysis for the Lentiviral Vector Contract Development and Manufacturing Organizations market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Lentiviral Vector Contract Development and Manufacturing Organizations market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Lentiviral Vector Contract Development and Manufacturing Organizations market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Oxford Biomedica
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • GenScript ProBio
  • Merck KGaA
  • Catalent Inc.
  • Ask Bio
  • Lonza
  • Curia Global, Inc.
  • Wuxi Advanced Therapies
  • SIRION Biotech GmbH
  • VGXI, Inc.
  • Yposkesi
  • Oxford Genetics Ltd.

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY COMPONENT

  • Lentiviral promoter
  • Lentiviral fusion tags
  • Lentivirus packaging systems
  • Others

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY DISEASE INDICATION

  • Cancer
  • Genetic disorders
  • Infectious diseases
  • Veterinary disease
  • Others

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY END USER

  • Pharmaceutical & biotech
  • Academic research
  • Others

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Component
    • 2.1.2. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Disease Indication
    • 2.1.3. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by End User
    • 2.1.4. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Country
    • 2.1.5. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Region
  • 2.2. Competitive Insights

3. Lentiviral Vector Contract Development and Manufacturing Organizations Key Market Trends

  • 3.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lentiviral Vector Contract Development and Manufacturing Organizations Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lentiviral Vector Contract Development and Manufacturing Organizations Market Opportunities
  • 3.4. Lentiviral Vector Contract Development and Manufacturing Organizations Market Future Trends

4. Lentiviral Vector Contract Development and Manufacturing Organizations Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lentiviral Vector Contract Development and Manufacturing Organizations Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Lentiviral Vector Contract Development and Manufacturing Organizations Market Landscape

  • 6.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lentiviral Vector Contract Development and Manufacturing Organizations Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
    • 7.1.2. Lentiviral promoter
    • 7.1.3. Lentiviral fusion tags
    • 7.1.4. Lentivirus packaging systems
    • 7.1.5. Others

8. Lentiviral Vector Contract Development and Manufacturing Organizations Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Genetic disorders
    • 8.1.4. Infectious diseases
    • 8.1.5. Veterinary disease
    • 8.1.6. Others

9. Lentiviral Vector Contract Development and Manufacturing Organizations Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Indication, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & biotech
    • 9.1.3. Academic research
    • 9.1.4. Others

10. Lentiviral Vector Contract Development and Manufacturing Organizations Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Lentiviral Vector Contract Development and Manufacturing Organizations Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Oxford Biomedica
    • 11.2.3. Charles River Laboratories International, Inc.
    • 11.2.4. Creative Biogene
    • 11.2.5. GenScript ProBio
    • 11.2.6. Merck KGaA
    • 11.2.7. Catalent Inc.
    • 11.2.8. Ask Bio
    • 11.2.9. Lonza
    • 11.2.10. Curia Global, Inc.
    • 11.2.11. Wuxi Advanced Therapies
    • 11.2.12. SIRION Biotech GmbH
    • 11.2.13. VGXI, Inc.
    • 11.2.14. Yposkesi
    • 11.2.15. Oxford Genetics Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Disease Indicationology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: Component Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component 2018-2030 (USD Million)
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: Disease Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication 2018-2030 (USD Million)
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: Regional snapshot (2022)
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Region 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Lentiviral Vector Contract Development and Manufacturing Organizations Market Segmentation
  • FIGURE Market research Disease Indicationology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Component segment market share analysis, 2022 & 2030
  • FIGURE Component segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Indication segment market share analysis, 2022 & 2030
  • FIGURE Disease Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE Germany Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE India Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE Brazil Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE Saudi Arabia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)